Skip to main content
Back to Trials
NCT06852053NARecruiting

Application to Predict Neonatal Apnea With Bradycardia

University of Alabama at Birmingham

Start Date

9/29/2026

Completion Date

12/31/2028

Summary

This purpose of this study is to reduce or stop apneas and bradycardias in pre-term infants, before they occur using gentle stimulation.

Detailed Description

This will be a randomized cross-over trial that will use additional ECG leads connected to a novel device and laptop to determine the accuracy and efficacy of an algorithm to predict, detect, and interrupt episodes of bradycardia for two 4-hour periods. There will be a 4-hour period without vibro-tactile stimulation and a 4-hour period with vibro-tactile stimulation when episodes are predicted or detected.

Eligibility Criteria

Age Range: No minimum to No maximum

Inclusion Criteria: * Documented episodes of apnea with bradycardia over the previous 24 hours. * Off ventilatory support/NCPAP for \> 48 hours prior to study entry * Gestational age \< 32 0/7 weeks' gestation at birth * Parents/legal guardians have provided consent for enrollment Exclusion Criteria: * a major malformation or a neuromuscular condition that affects respiration or causes apnea, or terminal illness or decision to withhold or limit support.

Interventions

DEVICE

Closed-loop Vibro-Tactile Stimulator

DEVICE

Control

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Apnea NeonatalBradycardia Neonatal

Locations

University of Alabama at Birmingham

Birmingham, Alabama 35209

United States